| Molecular Formula | C20H25ClN6O3 |
| Molar Mass | 432.9 |
| Density | 1.43±0.1 g/cm3(Predicted) |
| Melting Point | 58.5 °C |
| Boling Point | 660.6±65.0 °C(Predicted) |
| Solubility | DMSO: 37mg/mL, soluble |
| Appearance | solid |
| pKa | 2.81±0.25(Predicted) |
| Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.31 ml | 11.55 ml | 23.1 ml |
| 5 mM | 0.462 ml | 2.31 ml | 4.62 ml |
| 10 mM | 0.231 ml | 1.155 ml | 2.31 ml |
| 5 mM | 0.046 ml | 0.231 ml | 0.462 ml |
| biological activity | Purvalanol B (NG-95) is an effective and selective inhibitor of cyclin-dependent kinase (CDK), and its IC50 values for cdc2-cyclin B, CDK2-cyclin A, CDK2-cyclin E and CDK5-p35 are 6 nM, 6 nM, 9 nM and 6 nM respectively. |
| target | TargetValue cdc2-cyclin B (Cell-Free Assay) 6 nM CDK2-Cyclin A (Cell-Free Assay) 6 nM CDK5-P35 (Cell-Free Assay) 6 nM CDK2-Cyclin E (Cell-Free Assay) 9 nM |
| Target | Value |
| cdc2-cyclin B (Cell-free assay) | 6 nM |
| CDK2-Cyclin A (Cell-free assay) | 6 nM |
| CDK5-P35 (Cell-free assay) | 6 nM |
| CDK2-Cyclin E (Cell-free assay) | 9 nM |